Showing results (1071-1080 of 1,119) with videos related to

Sort By:
Pageof 112
Neurology. Genetics|November 3, 2025
Motor Function in Limb-Girdle Muscular Dystrophy R1/2A: Validation of Clinical Outcome Assessments for Clinical Care and Trial ReadinessMeredith K James, Megan A Iammarino, Natalie F Reash, et al.
Journal of the American College of Cardiology|May 28, 2025
Lipoprotein(a), Cholesterol, Triglyceride Levels, and Vulnerable Coronary Plaques: A PROSPECT II SubstudyDavid Erlinge, Sotirios Tsimikas, Michael Maeng, et al.
Lancet (London, England)|March 14, 2021
Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECT II): a prospective natural history studyDavid Erlinge, Akiko Maehara, Ori Ben-Yehuda, et al.
Atherosclerosis|February 22, 2023
Body weight at age 20 and in midlife is more important than weight gain for coronary atherosclerosis: Results from SCAPISGöran Bergström, Annika Rosengren, Elin Bacsovics Brolin, et al.
JACC. Cardiovascular Imaging|February 25, 2025
Association Between Physiological Significance and Vulnerable Plaque Characteristics in Patients With Myocardial Infarction: A Prospect II SubstudyKetina Arslani, Thomas Engstrøm, Michael Maeng, et al.
Journal of Neurology|May 26, 2026
Identification of prognostic biomarkers in a large cohort of patients with LGMD R2Carla F Bolano-Diaz, Jose Verdu-Diaz, Dan Hao, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 25, 2026
Linking Lipidomics to Vulnerable Coronary Plaques: A PROSPECT II SubstudyTania Sharma, Tove Fall, Sergi Sayols-Baixeras, et al.
European Heart Journal|March 23, 2017
Improving public health by improving clinical trial guidelines and their applicationMartin J Landray, Jeroen J Bax, Laurence Alliot, et al.
Environmental Microbiology Reports|November 29, 2016
The oil-contaminated soil diazotroph Azoarcus olearius DQS-4<sup>T</sup> is genetically and phenotypically similar to the model grass endophyte Azoarcus sp. BH72Helisson Faoro, Rodrigo Rene Menegazzo, Federico Battistoni, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 6, 2003
Long-term follow-up confirms a survival advantage of the paclitaxel-cisplatin regimen over the cyclophosphamide-cisplatin combination in advanced ovarian cancerM J Piccart, K Bertelsen, G Stuart, et al.
Pageof 112